Resource Center
Explore Resource Types
Focused Solutions
Biologics
Make advancements with precision biologics tools, designed to enhance your therapeutic approaches encompassing monoclonal antibodies, recombinant proteins, vaccines, and targeted next-generation cell and gene therapies.
Cell and Gene Therapy
The recent success of cell and gene therapies has paved the way for the next generation of advanced therapeutics. While challenges remain, cell and gene therapy research is seeing a transformational shift in the way that novel modalities, such as CAR-T, CRISPR, and vectors, are developed and delivered.
Disease Research
New drug modalities and targets are enabling us to live longer and healthier lives— but their development is grounded on a deep understanding of disease onset and progression.
Drug Development
The process of drug development comprises all the activities involved in bringing a new drug to market once a lead compound has been identified.
Functional Genomic Screening
Identify and characterize drug discovery targets with functional genomic screening services. Offering CRISPR knockout, CRISPR activation, CRISPR inhibition, dual screening and RNAi technologies
Integrated Lab Automation
From cellular screening and imaging applications to high-throughput screening and genomics-based applications, custom explorer™ G3 integrated workstations
Physiological Model Solutions
Drug discovery endeavors require a deep understanding of biological systems and their response to potential therapeutics.
Precision Medicine Research
Countless diseases, especially cancer, are highly heterogenous in nature which means a one-drug-fitsall approach isn’t practical for treating or fighting these diseases effectively.
Small Molecule Drug Discovery
With decades of experience in drug discovery driven by strong customer relationships, Revvity has developed an excellent product portfolio of drug discovery tools for complete solutions serving all parts of the discovery workflow.
All Resources
Filters
409 - 420 of 1187 Results
Streamlining single-cell sequencing workflows using Cellometer and Cellaca high-throughput cell counters
Procedura per la presentazione e gestione delle segnalazioni
Modern immuno-oncology assays enabled by high throughput image cytometry
Pennsylvania License 2023-2024 - Clinical Lab Permit
A qPCR Assay for Newborn Screening of Spinal Muscular Atrophy (SMA)
Newborn Screening Second Tier Molecular Testing is Critical for Identifying True Positives in Lysosomal Storage Diseases and X-linked Adrenoleukodystrophy
Rolling Circle Replication Based, Non Invasive Prenatal (NIPT) Assay Offers A Globally Accessible, High Precision, And Low-cost Prenatal Aneuploidy Screen
High Resolution Analysis Of D4Z4 Repeat Regions For Studying Facioscapulohumeral Muscular Dystrophy (FSHD) Using Whole Genome Optical Mapping
Real‐World Evidence Demonstrating Why Genome Sequencing Should Be Recommended as the First‐Tier Genetic Test
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.